Cartilage catabolism in arthritis: Factors that influence homeostasis

Expert Reviews in Molecular Medicine

Volumn 3, Issue 17, 2001, Pages 1-20

  Rowan, Andrew D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012472660     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399401003209     Document Type: Article

References (128)

1. Muir, H. (1995) The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 17, 1039–1048, PubMed ID: 96244356
2. Temenoff, J.S. and Mikos, A.G. (2000) Review: tissue engineering for regeneration of articular cartilage. Biomaterials 21, 431–440, PubMed ID: 20137272
3. Buckwalter, J.A. and Mankin, H.J. (1997) Articular cartilage. Part I: Tissue design and chondrocyte-matrix interactions. J Bone Joint Surg 79A, 600–611
4. Ganu, V. et al. (1998) Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Arthritis Rheum 41, 2143–2151, PubMed ID: 99086418
5. Lotz, M., Hashimoto, S. and Kuhn, K. (1999) Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage 7, 389–391, PubMed ID: 99350802
6. Scott, D.L. et al. (1998) The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. Br J Rheumatol 37, 546–554, PubMed ID: 98313104
7. Panayi, G.S. (1999) Targeting of cells involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 38 Suppl 2, 8–10, PubMed ID: 20111960
8. Nepom, G.T. and Nepom, B. (1998) Genetics of the major histocompatibility complex in rheumatoid arthritis. In Rheumatology (2nd edn) (Klippel, J.H. and Dieppe, P.A., eds), pp. 5.7.1–5.7.12, Mosby, London
9. Konttinen, Y.T. et al. (1998) New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol 17, 585–601, PubMed ID: 99120527
10. Miotla, J. et al. (2000) Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 80, 1195–1205, PubMed ID: 20405043
11. Paleolog, E. (1997) Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis. Mol Pathol 50, 225–233, PubMed ID: 98159346
12. van der Laan, W.H. et al. (2000) Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor. Arthritis Rheum 43, 1710–1718, PubMed ID: 20397776
13. Dodge, G.R. and Poole, A.R. (1989) Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 83, 647–661, PubMed ID: 89109582
14. van den Berg, W.B. (1998) Joint inflammation and cartilage destruction may occur uncoupled. Springer Semin Immunopathol 20, 149–164, PubMed ID: 99053094
15. Villiger, P.M., Terkeltaub, R. and Lotz, M. (1992) Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest 90, 488–496, PubMed ID: 92355784
16. Sen, M. et al. (2000) Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci U S A 97, 2791–2796, PubMed ID: 20183967
17. Shlopov, B.V., Gumanovskaya, M.L. and Hasty, K.A. (2000) Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum 43, 195–205, PubMed ID: 20106510
18. Goldring, M.B. (2000) Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2, 459–465, PubMed ID: 21064118
19. Buttle, D.J., Bramwell, H. and Hollander, A.P. (1995) Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy. J Clin Pathol 48M, M167-M177
20. Woessner, J.F., Jr and Nagase, H. (2000) Matrix Metalloproteinases and TIMPs, Oxford University Press, Oxford, UK
21. Murphy, G. and Reynolds, J.J. (1985) Current views of collagen degradation. Progress towards understanding the resorption of connective tissues. BioEssays 2, 55–60
22. Kozaci, L.D., Buttle, D.J. and Hollander, A.P. (1997) Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum 40, 164–174, PubMed ID: 97161355
23. Price, J.S. et al. (1999) Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum 42, 137–147, PubMed ID: 99116752
24. Cawston, T. (1998) Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol Med Today 4, 130–137, PubMed ID: 98236409
25. Brew, K., Dinakarpandian, D. and Nagase, H. (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477, 267–283, PubMed ID: 20175276
26. Clark, I.M., Rowan, A.D. and Cawston, T.E. (2000) Matrix metalloproteinase inhibitors in the treatment of arthritis. Curr Opin Anti-inflammatory Immunomodulatory Drugs 2, 16–25
27. McKie, N. et al. (1997) Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes. Biochem Biophys Res Commun 230, 335–339, PubMed ID: 97168971
28. Abbaszade, I. et al. (1999) Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274, 23443–23450, PubMed ID: 99367476
29. Tortorella, M.D. et al. (1999) Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284, 1664–1666, PubMed ID: 99286303
30. Kuno, K. et al. (2000) ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 478, 241–245, PubMed ID: 20389568
31. Vankemmelbeke, M.N. et al. (2001) Expression and activity of ADAMTS-5 in synovium. Eur J Biochem 268, 1259–1268, PubMed ID: 21153230
32. Kashiwagi, M. et al. (2001) Timp-3 is a potent inhibitor of aggrecanase 1 (adam-ts4) and aggrecanase 2 (adam-ts5). J Biol Chem 276, 12501–12504, PubMed ID: 21201070
33. Keyszer, G. et al. (1998) Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. Arthritis Rheum 41, 1378–1387, PubMed ID: 98368333
34. Creemers, L.B. et al. (1998) Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants. Matrix Biol 16, 575–584, PubMed ID: 98228081
35. Kafienah, W. et al. (1998) Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 331, 727–732, PubMed ID: 98228208
36. Saftig, P. et al. (2000) Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv Exp Med Biol 477, 293–303, PubMed ID: 20308303
37. Bryson, H. et al. (1998) A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokines. Arch Biochem Biophys 355, 15–25, PubMed ID: 98313240
38. Everts, V. et al. (1996) Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 28, 229–245, PubMed ID: 96358050
39. Culty, M., Nguyen, H.A. and Underhill, C.B. (1992) The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 116, 1055–1062, PubMed ID: 92129427
40. Yaeger, P.C. et al. (1997) Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res 237, 318–325, PubMed ID: 98096240
41. Fawthrop, F.W. et al. (1997) Effects of transforming growth factor beta on the production of prostaglandin E and caseinase activity of unstimulated and interleukin 1-stimulated human articular chondrocytes in culture. Br J Rheumatol 36, 729–734, PubMed ID: 97398976
42. Ohmori, Y., Smith, M.F., Jr. and Hamilton, T.A. (1996) IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 157, 2058–2065, PubMed ID: 96355010
43. Chou, H.H. et al. (2000) Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts. J Dent Res 79, 1683–1688, PubMed ID: 20476115
44. Goldring, M.B. (1999) The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40, 1–11, PubMed ID: 20231415
45. van den Berg, W.B. (2000) Arguments for interleukin 1 as a target in chronic arthritis. Ann Rheum Dis 59 Suppl 1, i81–84, PubMed ID: 20507133
46. McInnes, I.B. and Liew, F.Y. (1998) Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol Today 19, 75–79, PubMed ID: 98170502
47. Jovanovic, D.V. et al. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160, 3513–3521, PubMed ID: 98189800
48. Leistad, L., Ostensen, M. and Faxvaag, A. (1998) Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase- polymerase chain reaction. Scand J Rheumatol 27, 61–67, PubMed ID: 98165726
49. Studer, R.K. et al. (1999) Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis. Arthritis Rheum 42, 248–257, PubMed ID: 99148785
50. Olee, T. et al. (1999) IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 162, 1096–1100, PubMed ID: 99113776
51. Cawston, T.E. et al. (1998) The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 41, 1760–1771, PubMed ID: 98449666
52. Caterson, B. et al. (2000) Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol 19, 333–344, PubMed ID: 20420447
53. Isomaki, P. and Punnonen, J. (1997) Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 29, 499–507, PubMed ID: 98221008
54. Rowan, A.D. et al. (2001) Synergistic effects of gp130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum 44, 1620–1632, PubMed ID: 21358266
55. Henrotin, Y.E. et al. (1996) Effects of exogenous IL-1 beta, TNF alpha, IL-6, IL-8 and LIF on cytokine production by human articular chondrocytes. Osteoarthritis Cartilage 4, 163–173, PubMed ID: 97050489
56. Pulsatelli, L. et al. (1999) Chemokine production by human chondrocytes. J Rheumatol 26, 1992–2001, PubMed ID: 99421425
57. van den Berg, W.B., Joosten, L.A. and van de Loo, F.A. (1999) TNF alpha and IL-1 beta are separate targets in chronic arthritis. Clin Exp Rheumatol 17, S105–114, PubMed ID: 20056793
58. Lotz, M. (1999) The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 25, 269–282, PubMed ID: 99284905
59. Shuler, F.D. et al. (2000) Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res 18, 585–592, PubMed ID: 20505680
60. Goto, H. et al. (2000) Gene therapy for meniscal injury: enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGFbeta(1)gene. Osteoarthritis Cartilage 8, 266–271, PubMed ID: 20366445
61. Nixon, A.J. et al. (2000) Insulinlike growth factor-I gene therapy applications for cartilage repair. Clin Orthop S201–213, PubMed ID: 20492914
62. Smith, P. et al. (2000) Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 43, 1156–1164, PubMed ID: 20275271
63. Nakanishi, T. et al. (2000) Effects of CTGF/ Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 141, 264–273, PubMed ID: 20080284
64. Fischer, D.C. et al. (1999) Induction of alpha1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: evidence for a local acute-phase response in the joint. Arthritis Rheum 42, 1936–1945, PubMed ID: 99441968
65. Li, W.Q. and Zafarullah, M. (1998) Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase-and mitogen-activated protein kinase-dependent mechanisms. J Immunol 161, 5000–5007, PubMed ID: 99008568
66. Hui, W., Rowan, A.D. and Cawston, T. (2001) Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha. Ann Rheum Dis 60, 254–261, PubMed ID: 21091711
67. Smeets, T.J. et al. (2000) The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis. Arthritis Rheum 43, 270–274, PubMed ID: 20155532
68. Morales, T.I. (1994) Transforming growth factor-beta and insulin-like growth factor-1 restore proteoglycan metabolism of bovine articular cartilage after depletion by retinoic acid. Arch Biochem Biophys 315, 190–198, PubMed ID: 95070163
69. Bakker, A.C. et al. (2001) Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 9,128–136, PubMed ID: 21138040
70. Martin, J.A. and Buckwalter, J.A. (2000) The role of chondrocyte-matrix interactions in maintaining and repairing articular cartilage. Biorheology 37, 129–140, PubMed ID: 20369886
71. Langdon, C. et al. (2000) Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol 157, 1187–1196, PubMed ID: 20476205
72. Cleaver, C.S., Rowan, A.D. and Cawston, T.E. (2001) Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines. Ann Rheum Dis 60, 150–157, PubMed ID: 21068302
73. Cawston, T.E. et al. (1996) Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines. Biochim Biophys Acta 1314, 226–232, PubMed ID: 97136899
74. Loeser, R.F. (2000) Chondrocyte integrin expression and function. Biorheology 37, 109–116, PubMed ID: 20369884
75. Jalali, S. et al. (2001) Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. Proc Natl Acad Sci U S A 98, 1042–1046, PubMed ID: 21107667
76. Attur, M.G. et al. (2000) Functional genomic analysis in arthritis-affected cartilage: yin-yang regulation of inflammatory mediators by alpha 5 beta 1 and alpha V beta 3 integrins. J Immunol 164, 2684–2691, PubMed ID: 20143864
77. Badger, A.M. et al. (2001) Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis. Arthritis Rheum 44, 128–137, PubMed ID: 21079685
78. Martel-Pelletier, J. et al. (1992) The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 35, 530–540, PubMed ID: 92247049
79. Alsalameh, S. et al. (1999) Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor. J Rheumatol 26, 645–653, PubMed ID: 99188563
80. Westacott, C.I. et al. (2000) Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 8, 213–221, PubMed ID: 20268130
81. Amin, A.R. (1999) Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis. Osteoarthritis Cartilage 7, 392–394, PubMed ID: 99350803
82. Chow, G. et al. (1998) Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis. Arthritis Rheum 41, 1411–1419, PubMed ID: 98368337
83. Silacci, P. et al. (1998) Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity. J Biol Chem 273, 13625–13629, PubMed ID: 98256284
84. Robak, T. et al. (1998) Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Mediators Inflamm 7, 347–353, PubMed ID: 99098439
85. MacGregor, A.J. and Silman, A.J. (1998) Classification and epidemiology in rheumatoid arthritis. In Rheumatology (2nd edn) (Klippel, J.H. and Dieppe, P.A., eds), pp. 5.2.1–5.2.6, Mosby, London
86. Woo, P. (2000) Cytokine polymorphisms and inflammation. Clin Exp Rheumatol 18, 767–771, PubMed ID: 21020348
87. Clague, R.B. et al. (1983) Serum antibodies to type II collagen in rheumatoid arthritis: comparison of 6 immunological methods and clinical features. Ann Rheum Dis 42, 537–544, PubMed ID: 84022742
88. Nakagawa, K. et al. (1999) Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody. Ann Rheum Dis 58, 175–181, PubMed ID: 99293250
89. Yamaguchi, K. et al. (1990) Degradation of type I and II collagen by human activated C1-s. FEBS Lett 268, 206–208, PubMed ID: 90346138
90. Firestein, G.S. and Manning, A.M. (1999) Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum 42, 609–621, PubMed ID: 99226856
91. Catterall, J.B. et al. Synergistic induction of matrix metalloproteinase-1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator of protein-1 transcription factors via a novel mechanism. Arthritis Rheum 44 (in press)
92. Clark, I.M. et al. (1997) Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J 324, 611–617, PubMed ID: 97307877
93. Starr, R. et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387, 917–921, PubMed ID: 97345633
94. Freije, J.M. et al. (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269, 16766–16773, PubMed ID: 94266894
95. Balbin, M. et al. (2001) Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem 276, 10253–10262, PubMed ID: 21167837
96. Konttinen, Y.T. et al. (1999) Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58, 691–697, PubMed ID: 20001911
97. van Lent, P.L. et al. (2000) Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis. Arthritis Rheum 43, 740–752, PubMed ID: 20226985
98. Mudgett, J.S. et al. (1998) Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 41, 110–121, PubMed ID: 98093965
99. Vu, T.H. et al. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411–422, PubMed ID: 98250057
100. Holmbeck, K. et al. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81–92, PubMed ID: 99449306
101. Zhou, Z. et al. (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A 97, 4052–4057, PubMed ID: 20226056
102. Zhao, J. et al. (2001) Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev Biol 232, 204–218, PubMed ID: 21153176
103. Shindo, T. et al. (2000) ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest 105, 1345–1352, PubMed ID: 20273926
104. Goater, J. et al. (2000) Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J Rheumatol 27, 983–989, PubMed ID: 20242921
105. Li, J. et al. (1995) Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 3, 541–549, PubMed ID: 96173003
106. Cawston, T.E. and Rowan, A. (1998) Prevention of cartilage breakdown by matrix metalloproteinase inhibition-a realistic therapeutic target? Br J Rheumatol 37, 353–356, PubMed ID: 98281180
107. Brennan, F.M. et al. (1997) Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti- tumour necrosis factor-alpha (cA2) therapy. Br J Rheumatol 36, 643–650, PubMed ID: 97379874
108. Probert, L. et al. (1995) The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur J Immunol 25, 1794–1797, PubMed ID: 95339901
109. Jouvenne, P. et al. (1998) Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction. Arthritis Rheum 41, 1083–1089, PubMed ID: 98288707
110. Bresnihan, B. et al. (1998) Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41, 2196–2204, PubMed ID: 99086423
111. Bessis, N. et al. (2000) The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur J Immunol 30, 867–875, PubMed ID: 20203444
112. Niki, Y. et al. (1998) Membrane-associated IL-1 contributes to chronic synovitis in human IL-1RA transgenic mice. Arthritis Rheum 41, S212
113. Zheng, H. et al. (1995) Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity 3, 9–19, PubMed ID: 95346514
114. van den Berg, W.B. (1997) Lessons for joint destruction from animal models. Curr Opin Rheumatol 9, 221–228, PubMed ID: 97348206
115. Mori, L. et al. (1996) Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J Immunol 157, 3178–3182, PubMed ID: 96413269
116. van de Loo, F.A. et al. (1997) Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. Am J Pathol 151, 177–191, PubMed ID: 97356308
117. de Hooge, A.S. et al. (2000) Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis. Am J Pathol 157, 2081–2091, PubMed ID: 20560568
118. Chan, S.Y. and Wong, R.W. (2000) Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 275, 38693–38698, PubMed ID: 20556317
119. Manoury-Schwartz, B. et al. (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN- gamma receptors. J Immunol 158, 5501–5506, PubMed ID: 97307631
120. Blom, A.B. et al. (2000) Fc gamma R expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA). Arthritis Res 2, 489–503, PubMed ID: 21062458
121. Tsuji, M. et al. (2000) The possible role of c-fos expression in rheumatoid cartilage destruction. J Rheumatol 27, 1606–1621, PubMed ID: 20370525
122. Mi, Z. et al. (2000) Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum 43, 2563–2570, PubMed ID: 20534252
123. Studer, R.K. et al. (2000) Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF- IRbeta tyrosine phosphorylation. Am J Physiol Cell Physiol 279, C961–969, PubMed ID: 20459423
124. Lubberts, E. et al. (1999) Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 163, 4546–4556, PubMed ID: 99441379
125. Cottard, V. et al. (2000) Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis. Gene Ther 7, 1930–1939, PubMed ID: 21010713
126. Bessis, N. et al. (1999) Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA). Clin Exp Immunol 117, 376–382, PubMed ID: 99373644
127. Bondeson, J. et al. (2000) Effective adenoviral transfer of IkappaBalpha into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-kappaB dependent. J Rheumatol 27, 2078–2089, PubMed ID: 20443624
128. Rawlings, N.D. and Barrett, A.J. (2000) MEROPS: the peptidase database. Nucleic Acids Res 28, 323–325, PubMed ID: 20063295